SirolimusImmunosuppressive AgentsTacrolimusKidney TransplantationCyclosporineMycophenolic AcidCalcineurinGraft RejectionDrug SubstitutionTreatment OutcomeLymphangioleiomyomatosisAngiomyolipomaTOR Serine-Threonine KinasesDrug Therapy, CombinationGraft SurvivalLymphangiomyomaInjections, IntraocularCoronary RestenosisTime FactorsChyleLiver TransplantationTransplantation, HomologousDrug-Eluting StentsPolyenesCreatinineKidneyCardiovascular AgentsDrug MonitoringFollow-Up StudiesAntibiotics, AntineoplasticDrug ImplantsStentsIslets of Langerhans TransplantationGlomerular Filtration RateTransplantationImmunosuppressionFluorescence Polarization ImmunoassayDose-Response Relationship, DrugTubulin ModulatorsRetrospective StudiesThrombotic MicroangiopathiesOxaloacetic AcidCoated Materials, BiocompatibleDrug InteractionsProspective StudiesDrug Administration ScheduleCitrus paradisiAzathioprinePolycystic Kidney, Autosomal DominantHeart TransplantationPaclitaxelAcetic AnhydridesAdministration, OralDouble-Blind MethodUnrelated DonorsAntilymphocyte SerumTuberous SclerosisRenal InsufficiencyPilot ProjectsKidney Function TestsOral UlcerAdrenal Cortex HormonesBiopsyPerivascular Epithelioid Cell NeoplasmsRibosomal Protein S6 Kinases, 70-kDaPostoperative ComplicationsBiliary FistulaBenzenesulfonatesIntention to Treat AnalysisKetoconazoleClinical AuditAbsorbable ImplantsSteroidsTransplantation ConditioningRespiratory System AgentsMucoralesOligomenorrheaAntibodies, MonoclonalDrug CombinationsCoronary AngiographyAntibodies, Monoclonal, HumanizedProteinuriaCytochrome P-450 CYP3AGraft Occlusion, VascularKaplan-Meier EstimateLiving DonorsGraft vs Host Disease